Translational Imaging to improve probability of success in drug development

Join us on the 14th and 15th March 2012 at the Copthorne Tara Hotel to gain top tips from experienced industry figures discussing ways in which to develop drugs in a clever way with reduced production time
Spread the Word
Listed Under

* Molecular
* Imaging
* Translational Imaging
* Biomarkers
* Cancer
* Oncology
* In-vivo
* Pet
* Mri
* Ultrasound
* Clinical Trials

* Pharmaceuticals

* England

* Services

Jan. 31, 2012 - PRLog -- Join SMi at their 8th annual Imaging in Cancer Drug Development conference that promises to be interactive and informative. With an increasing verity of imaging modalities available and each of them offering benefits at different stages and in different ways, there is a great deal of benefit that can be gained from their implementation.

You will hear from industry experts on the current applications of imaging in all stages of drug design, in depth verity of imaging modalities and how they can be best applied in the development process, how to use imaging techniques to reduce the long term cost of drug development and case studies discussions on how to best standardize imaging result from multi centre clinical trials

Benefits of attending

Examine the benefits of different imaging modalities and she how they can be best applied in your investigations

Review case studies on the use of imaging in multi centre clinical trials and how different teams have overcome the challenges associated with them.

Determine how upcoming EU regulations will affect the way oncology trials use of imaging will be conducted

Gain knowledge of using imaging techniques, when used, can reduce the long term cost of drug development

Communicate with industry experts on the current applications of imaging in all stages of drug design

Participate at the interactive workshop on how molecular imaging can reduce the cost of drug development

Make sure not to miss this opportunity to attend and hear from our expert speakers, including:

•   Werner Scheuer, Research Leader Preclinical Imaging, Roche Diagnostics
•   Yanping Luo, Group Leader Translational Imaging, Abbott
•   Peter Eggelton, Medical Director Oncology, Merck
•   Paul McSheehy, Director Oncology, Novartis
•   Anthony M Giamis, Head of Radiochemistry, Abbott
•   Christopher Foley, Imaging Manager, GlaxoSmithKline
•   Simon Walker-Samuel, Senior Research Associate, University College London
•   Francois Lassailly, In-vivo Imaging Specialist, Cancer Research

Please visit:
Alternatively contact: Ninica Hussain 0207 827 6115 or
Source:SMi Group
Email:*** Email Verified
Tags:Molecular, Imaging, Translational Imaging, Biomarkers, Cancer, Oncology, In-vivo, Pet, Mri, Ultrasound, Clinical Trials
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Daily News
Weekly News

Like PRLog?
Click to Share